Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001663577-25-000110
Filing Date
2025-04-14
Accepted
2025-04-14 16:56:22
Documents
58
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT skvi10k123124.htm   iXBRL 10-K 637545
2 GRAPHIC image_100.jpg GRAPHIC 6553
3 GRAPHIC image_101.jpg GRAPHIC 11785
4 GRAPHIC image_001.jpg GRAPHIC 3352
5 CERTIFICATION ex31_1.htm EX-31.1 9006
6 CERTIFICATION ex31_2.htm EX-31.2 9003
7 CERTIFICATION ex32_1.htm EX-32.1 3952
  Complete submission text file 0001663577-25-000110.txt   3183983

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE skvi-20241231.xsd EX-101.SCH 25461
9 XBRL CALCULATION FILE skvi-20241231_cal.xml EX-101.CAL 39436
10 XBRL DEFINITION FILE skvi-20241231_def.xml EX-101.DEF 78276
11 XBRL LABEL FILE skvi-20241231_lab.xml EX-101.LAB 191913
12 XBRL PRESENTATION FILE skvi-20241231_pre.xml EX-101.PRE 167648
61 EXTRACTED XBRL INSTANCE DOCUMENT skvi10k123124_htm.xml XML 294810
Mailing Address 6320 S SANDHILL ROAD UNIT 9 LAS VEGAS NV 89120
Business Address 6320 S SANDHILL ROAD UNIT 9 LAS VEGAS NV 89120 702-433-7154
SKINVISIBLE, INC. (Filer) CIK: 0001085277 (see all company filings)

EIN.: 880344219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-25911 | Film No.: 25836588
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)